Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | PVX-410 |
| Trade Name | |
| Synonyms | PVX 410|PVX410 |
| Drug Descriptions |
PVX-410 is a multipeptide vaccine that may stimulate anti-tumor immune response (PMID: 30128502). |
| DrugClasses | |
| CAS Registry Number | NA |
| NCIT ID | C103823 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Durvalumab + Lenalidomide + PVX-410 | Durvalumab Lenalidomide PVX-410 | 0 | 1 |
| Durvalumab + Poly ICLC + PVX-410 | Durvalumab PVX-410 Poly ICLC | 0 | 1 |
| Durvalumab + PVX-410 | Durvalumab PVX-410 | 0 | 1 |
| Lenalidomide + PVX-410 | Lenalidomide PVX-410 | 0 | 0 |
| Melphalan + PVX-410 | Melphalan PVX-410 | 0 | 1 |
| Pembrolizumab + PVX-410 | PVX-410 Pembrolizumab | 0 | 1 |
| PVX-410 | PVX-410 | 0 | 0 |